Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001438533-20-000031
Filing Date
2020-11-05
Accepted
2020-11-05 16:51:33
Documents
89
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rtrx-20200930.htm   iXBRL 10-Q 1655494
2 EX-10.1 rtrx-20200930xex101.htm EX-10.1 249453
3 EX-10.2 rtrx20200930ex102.htm EX-10.2 64231
4 EX-31.1 ex09302020311.htm EX-31.1 12778
5 EX-31.2 ex09302020312.htm EX-31.2 12452
6 EX-32.1 ex09302020321.htm EX-32.1 8837
7 EX-32.2 ex09302020322.htm EX-32.2 8907
13 rtrx-20200930_g1.jpg GRAPHIC 62684
  Complete submission text file 0001438533-20-000031.txt   7969452

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rtrx-20200930.xsd EX-101.SCH 48259
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rtrx-20200930_cal.xml EX-101.CAL 104486
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rtrx-20200930_def.xml EX-101.DEF 240720
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rtrx-20200930_lab.xml EX-101.LAB 593069
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rtrx-20200930_pre.xml EX-101.PRE 409655
14 EXTRACTED XBRL INSTANCE DOCUMENT rtrx-20200930_htm.xml XML 1267965
Mailing Address 3721 VALLEY CENTRE DR. SUITE 200 SAN DIEGO CA 92130
Business Address 3721 VALLEY CENTRE DR. SUITE 200 SAN DIEGO CA 92130 760-260-8600
Retrophin, Inc. (Filer) CIK: 0001438533 (see all company filings)

EIN.: 262383102 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36257 | Film No.: 201291286
SIC: 2834 Pharmaceutical Preparations